The role of reproductive hormone metabolites in gestational alterations in lipid and bile metabolism

Pregnant women with a liver disorder called intrahepatic cholestasis of pregnancy (ICP) have sharply elevated levels of sulphated progesterone metabolites (P4S), and these compounds may be driving the condition. The problem is that ICP is poorly understood. It causes bile acids to build up in the liver and bloodstream, leading to severe itching for the mother and raising risks of preterm birth, stillbirth, and later-life maternal liver disease. Current treatments, such as the drug ursodeoxycholic acid, are used without a clear understanding of how they work in this context. The researchers have discovered that P4S can activate FXR, the main bile acid receptor, suggesting a direct link between pregnancy hormones and bile acid disruption. If this research succeeds, it could explain why some women develop ICP and why it recurs in later pregnancies. It may also reveal why ursodeoxycholic acid helps some patients but not others, and whether targeting P4S or FXR could lead to better treatments. In the longer term, this fundamental science could reshape how clinicians manage liver function during pregnancy, reducing complications for both mother and child.